Creative Planning’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-600
Closed -$1K 2271
2021
Q1
$1K Hold
600
﹤0.01% 2585
2020
Q4
$1K Buy
+600
New +$36.2K ﹤0.01% 2321
2020
Q3
Sell
-100
Closed -$1K 2194
2020
Q2
$1K Sell
100
-300
-75% -$23K ﹤0.01% 1986
2020
Q1
$2K Buy
+400
New +$27.6K ﹤0.01% 1822
2019
Q4
Sell
-1,400
Closed -$1K 2042
2019
Q3
$1K Hold
1,400
﹤0.01% 1969
2019
Q2
$4K Hold
1,400
﹤0.01% 1963
2019
Q1
$4K Sell
1,400
-1,700
-55% -$113K ﹤0.01% 1916
2018
Q4
$5K Sell
3,100
-500
-14% -$34.9K ﹤0.01% 1867
2018
Q3
$30K Buy
3,600
+1,900
+112% +$143K ﹤0.01% 1916
2018
Q2
$3K Sell
1,700
-200
-11% -$14.1K ﹤0.01% 1990
2018
Q1
$10K Buy
+1,900
New +$151K ﹤0.01% 1931
2017
Q3
Sell
-6,000
Closed -$13K 2601
2017
Q2
$13K Buy
6,000
+1,000
+20% +$66.5K ﹤0.01% 3460
2017
Q1
$6K Buy
5,000
+500
+11% +$35.2K ﹤0.01% 3869
2016
Q4
$8K Buy
4,500
+3,000
+200% +$223K ﹤0.01% 3684
2016
Q3
$8K Sell
1,500
-100
-6% -$8.12K ﹤0.01% 3644
2016
Q2
$1K Buy
1,600
+600
+60% +$53.2K ﹤0.01% 4160
2016
Q1
$2K Sell
1,000
-100
-9% -$9.02K ﹤0.01% 3943
2015
Q4
$10K Sell
1,100
-200
-15% -$20.8K ﹤0.01% 3295
2015
Q3
$12K Buy
+1,300
New +$144K ﹤0.01% 3074
2015
Q2
Sell
-5,800
Closed -$53K 1827
2015
Q1
$53K Sell
5,800
-8,500
-59% -$863K ﹤0.01% 1993
2014
Q4
$100K Buy
14,300
+4,200
+42% +$434K ﹤0.01% 1552
2014
Q3
$121K Sell
10,100
-4,900
-33% -$480K ﹤0.01% 1346
2014
Q2
$87K Buy
15,000
+10,000
+200% +$778K ﹤0.01% 1527
2014
Q1
$17K Buy
+5,000
New +$392K ﹤0.01% 2478

Other funds holding GILD

Creative Planning's GILD Position: Q1 2026 in Review

Creative Planning increased its Gilead Sciences (GILD) stake by 24% in Q1 2026, buying an estimated $11.2M and bringing the position to 409,391 shares worth $57.1M. The position accounts for 0.04% of the portfolio, ranked #195.

Creative Planning first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Creative Planning held 409,391 shares of Gilead Sciences worth $57.1M as of Q1 2026.
  • Creative Planning bought 80,030 Gilead Sciences shares in Q1 2026, an estimated $11.2M.
  • Gilead Sciences made up 0.04% of Creative Planning's portfolio in Q1 2026, its #195 holding.
  • Creative Planning first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.